Massively Parallel Functional Analysis of Missense Mutations In BRCA1... - Lea Starita
BRCA Variant Classification 2021 (Run 6) Webinar 2
Massively Parallel Validation of Cancer Mutations and Other Variants... - Georges Natsoulis
Massively Parallel Sequencing as an investigative tool
Dr Daniel Trujillano - Next-generation sequencing of the BRCA1 and BRCA2 genes: Ion World Tour 2014
Dr. Lea Starita (Mutational Scanning Symposium 2021)
BRCA variant classification 2018 (Run 2) Q & A
25 years after BRCA discovery: History, enigma, and lessons for the future - Pr David Goldgar
Introduction to Missense Variants by Dr Julian Barwell
Ensuring accurate classification of variants in BRCA1, BRCA2 and HRR genes (2023) - webinar 1
A Massively Parallel In Vivo Enhancer Assay Reveals that... - Michael A. White - RECOMB/RSG 2013
BRCA1 - Tales from the Genome
MCB 182 Lecture 8.6 - Massively parallel reporter assays (MPRA)
Nadav Ahituv, PhD - Functional Characterization of Gene Regulatory Elements
BRCA1 Mutations
Variant Interpretation Challenges & Use Cases | Leveraging Mastermind in the Clinical Lab
What does missense mutation mean?
Determining if a missense variant is the cause of disease by Claire Green
The use of massively parallel sequencing in Forensic DNA typing - what will the future hold?
Whole Exome Analysis for VUS Resolution
Decoding Transcriptional Regulation by Genome-Wide Reporter Assays and Large-Scale Transfection
BRCA1 demo 2
The “BRCA-Like” Phenotype in Cancer
Massively parallel sequencing: Integrating the Ion PGM™ Sequencer into a forensics lab - HIDS 2015
Beyond BRCA Mutations: What's New in the World of Genetic Testing
